Close Menu

NEW YORK (GenomeWeb) – Biotage, a Swedish firm specializing in separation technologies, said today it has signed a strategic collaboration with Shandong Yingsheng Biotechnology (Yingsheng) to develop clinical mass spectrometry applications in China.

Terms of the deal call for Biotage to provide systems and consumables from its analytical chemistry portfolio to be sold by Yingsheng under its own brand and together with Yingsheng's other products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.